Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hurst

Showing results (201-210 of 276) with videos related to

Pageof 28
Sort By:
Molecular Pharmacology|March 3, 1999
Role of a conserved lysine residue in the peripheral cannabinoid receptor (CB2): evidence for subtype specificityQ Tao, S D McAllister, J Andreassi, et al.
Chemmedchem|March 26, 2018
Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone-Based Cannabinoid Receptor Type 2 LigandsGiulio Ragusa, Serena Bencivenni, Paula Morales, et al.
Cannabis and Cannabinoid Research|July 6, 2022
The NPXXY Motif Regulates β-Arrestin Recruitment by the CB1 Cannabinoid ReceptorLuciana M Leo, Rufaida Al-Zoubi, Dow P Hurst, et al.
Molecular Pharmacology|November 19, 2002
N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A) interaction with LYS 3.28(192) is crucial for its inverse agonism at the cannabinoid CB1 receptorDow P Hurst, Diane L Lynch, Judy Barnett-Norris, et al.
Biochemical Pharmacology|July 12, 2002
A critical role for a tyrosine residue in the cannabinoid receptors for ligand recognitionSean D McAllister, Qing Tao, Judy Barnett-Norris, et al.
Molecular Pharmacology|September 15, 2005
(-)-7'-Isothiocyanato-11-hydroxy-1',1'-dimethylheptylhexahydrocannabinol (AM841), a high-affinity electrophilic ligand, interacts covalently with a cysteine in helix six and activates the CB1 cannabinoid receptorRobert P Picone, Atmaram D Khanolkar, Wei Xu, et al.
Frontiers in Immunology|May 1, 2018
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat TreatmentCory H White, Nadejda Beliakova-Bethell, Steven M Lada, et al.
Frontiers in Pharmacology|November 17, 2022
Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593Asher L Brandt, Sumanta Garai, Ayat Zagzoog, et al.
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|January 23, 2016
A longitudinal mediational study on the stability of alexithymia among alcohol-dependent outpatients in cognitive-behavioral therapyFred Arne Thorberg, Ross McD Young, Karen A Sullivan, et al.
BMC Cancer|August 30, 2014
Differential subcellular and extracellular localisations of proteins required for insulin-like growth factor- and extracellular matrix-induced signalling events in breast cancer progressionHelen C Plant, Abhishek S Kashyap, Kerry J Manton, et al.
Pageof 28

Showing results (201-210 of 276) with videos related to

Sort By:
Pageof 28
Molecular Pharmacology|March 3, 1999
Role of a conserved lysine residue in the peripheral cannabinoid receptor (CB2): evidence for subtype specificityQ Tao, S D McAllister, J Andreassi, et al.
Chemmedchem|March 26, 2018
Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone-Based Cannabinoid Receptor Type 2 LigandsGiulio Ragusa, Serena Bencivenni, Paula Morales, et al.
Cannabis and Cannabinoid Research|July 6, 2022
The NPXXY Motif Regulates β-Arrestin Recruitment by the CB1 Cannabinoid ReceptorLuciana M Leo, Rufaida Al-Zoubi, Dow P Hurst, et al.
Molecular Pharmacology|November 19, 2002
N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A) interaction with LYS 3.28(192) is crucial for its inverse agonism at the cannabinoid CB1 receptorDow P Hurst, Diane L Lynch, Judy Barnett-Norris, et al.
Biochemical Pharmacology|July 12, 2002
A critical role for a tyrosine residue in the cannabinoid receptors for ligand recognitionSean D McAllister, Qing Tao, Judy Barnett-Norris, et al.
Molecular Pharmacology|September 15, 2005
(-)-7'-Isothiocyanato-11-hydroxy-1',1'-dimethylheptylhexahydrocannabinol (AM841), a high-affinity electrophilic ligand, interacts covalently with a cysteine in helix six and activates the CB1 cannabinoid receptorRobert P Picone, Atmaram D Khanolkar, Wei Xu, et al.
Frontiers in Immunology|May 1, 2018
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat TreatmentCory H White, Nadejda Beliakova-Bethell, Steven M Lada, et al.
Frontiers in Pharmacology|November 17, 2022
Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593Asher L Brandt, Sumanta Garai, Ayat Zagzoog, et al.
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|January 23, 2016
A longitudinal mediational study on the stability of alexithymia among alcohol-dependent outpatients in cognitive-behavioral therapyFred Arne Thorberg, Ross McD Young, Karen A Sullivan, et al.
BMC Cancer|August 30, 2014
Differential subcellular and extracellular localisations of proteins required for insulin-like growth factor- and extracellular matrix-induced signalling events in breast cancer progressionHelen C Plant, Abhishek S Kashyap, Kerry J Manton, et al.
Pageof 28